Search Results for compounds
Searching compounds for 5,5 89 3 returned 2016 results.
Displaying compounds 1351 - 1375 of 2016 in total
T3D0781
103-72-0
T3D1294
289-31-6
arsinine
Matched carcinogenicity: … 3, not classifiable as to its carcinogenicity to humans. (L135) …
T3D1297
7784-36-3
T3D1328
19781-14-3
T3D1340
1762-26-1
ethyltrimethylplumbane
Matched carcinogenicity: … Organic lead compounds are not classifiable as to their carcinogenicity to humans (Group 3). To the …
T3D1417
1314-06-3
T3D1434
24094-93-7
chromiumylidyneamine
Matched carcinogenicity: … 3, not classifiable as to its carcinogenicity to humans. (L135) …
T3D1676
6317-18-6
T3D1681
4044-65-9
T3D1696
109-74-0
T3D1701
1194-65-6
T3D1713
3333-52-6
T3D2338
52025-76-0
10-methyl-5-pentyl-13-(prop-1-en-2-yl)-8-oxatricyclo[7.4.0.0²,⁷]trideca-2(7),3,5-triene-3,10-diol
T3D2453
16568-02-8
N'-[(1E)-ethylidene]-N-methylformohydrazide
Matched carcinogenicity: … 3, not classifiable as to its carcinogenicity to humans. (L135) …
T3D2882
26675-46-7
2-chloro-2-(difluoromethoxy)-1,1,1-trifluoroethane
Matched toxicity: … LC50=15300 ppm/3 hrs (inhalation by rat) …
T3D2988
22916-47-8
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
Matched toxicity: … LD50: 3800 mg/kg (Oral, Mouse) (A308)
LD50: 3 gm/kg (Oral, Rat) (A308) …
T3D3000
52128-35-5
N-[(2,4-diimino-5-methyl-1,2,3,4-tetrahydroquinazolin-6-yl)methyl]-3,4,5-trimethoxyaniline
Matched treatment: … In the event of overdose, Trimetrexate should be stopped and leucovorin should be administered at a dose of 40 mg/m2 every 6 hours for 3 days. (L1712) …
T3D3036
93390-81-9
[(2-hydroxy-5-oxo-4,4-diphenyl-4,5-dihydro-1H-imidazol-1-yl)methoxy]phosphonic acid
Matched synonyms: … (3-Phosphoryloxymethyl)phenytoin …
T3D3209
123-77-3
T3D3430
463-82-1
T3D3469
9003-20-7
butan-2-yl acetate
Matched carcinogenicity: … 3, not classifiable as to its carcinogenicity to humans. (L135) …
T3D3556
16774-21-3
T3D3563
10421-48-4
